These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34238613)

  • 1. Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors.
    Hillman RT; Lin DI; Lawson B; Gershenson DM
    Gynecol Oncol; 2021 Sep; 162(3):728-734. PubMed ID: 34238613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
    Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
    J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
    Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
    Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.
    Färkkilä A; McConechy MK; Yang W; Talhouk A; Ng Y; Lum A; Morin RD; Bushell K; Riska A; McAlpine JN; Gilks CB; Unkila-Kallio L; Anttonen M; Huntsman DG
    J Mol Diagn; 2017 Jan; 19(1):126-136. PubMed ID: 27810330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary.
    D'Angelo E; Mozos A; Nakayama D; Espinosa I; Catasus L; Muñoz J; Prat J
    Mod Pathol; 2011 Oct; 24(10):1360-7. PubMed ID: 21623383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.
    Lin DI; Fine A; Danziger NA; Huang RSP; Mata DA; Decker B; Killian JK; Ramkissoon SH; Lechpammer M; Janovitz T; Ross JS; Sokol ES; Elvin JA
    Gynecol Oncol; 2022 Mar; 164(3):558-565. PubMed ID: 34998597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
    How JA; Jazaeri A; Westin SN; Sood AK; Ramondetta LM; Xu M; Abonofal A; Karp DD; Subbiah V; Stephen B; Rodon JA; Yang F; Naing A
    Invest New Drugs; 2021 Jun; 39(3):829-835. PubMed ID: 33415580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular assessment of testicular adult granulosa cell tumor demonstrates significant differences when compared to ovarian counterparts.
    Siegmund S; Sholl LM; Cornejo KM; Sangoi AR; Otis CN; Mehra R; Hirsch MS; Acosta AM
    Mod Pathol; 2022 May; 35(5):697-704. PubMed ID: 34845303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
    Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ
    Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.
    Fashedemi Y; Coutts M; Wise O; Bonhomme B; Baker G; Kelly PJ; Soubeyran I; Catherwood MA; Croce S; McCluggage WG
    Am J Surg Pathol; 2019 Sep; 43(9):1229-1238. PubMed ID: 31162286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.
    McConechy MK; Färkkilä A; Horlings HM; Talhouk A; Unkila-Kallio L; van Meurs HS; Yang W; Rozenberg N; Andersson N; Zaby K; Bryk S; Bützow R; Halfwerk JB; Hooijer GK; van de Vijver MJ; Buist MR; Kenter GG; Brucker SY; Krämer B; Staebler A; Bleeker MC; Heikinheimo M; Kommoss S; Blake Gilks C; Anttonen M; Huntsman DG
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27297428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
    Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
    Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
    Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
    Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup.
    Roze J; Monroe G; Kutzera J; Groeneweg J; Stelloo E; Paijens S; Nijman H; Meurs HV; Lonkhuijzen LV; Piek J; Lok C; Jonges G; Witteveen P; Verheijen R; Haaften GV; Zweemer R
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors.
    Shao C; Li G; Huang L; Pruitt S; Castellanos E; Frampton G; Carson KR; Snow T; Singal G; Fabrizio D; Alexander BM; Jin F; Zhou W
    JAMA Netw Open; 2020 Oct; 3(10):e2025109. PubMed ID: 33119110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.
    Pierini S; Tanyi JL; Simpkins F; George E; Uribe-Herranz M; Drapkin R; Burger R; Morgan MA; Facciabene A
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.